Incidence de la séroconversion de l’hépatite virale B et du VIH chez les hémodialysés chroniques à Douala, Cameroun

Halle, M.P.; Boumsso, S.L. Ngo; Folefack, F. Kaze; Fouda, Hermine; Ashuntantang, Gloria; Luma, Henry Namme

doi:10.1016/j.nephro.2016.07.029

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…EL YOUBI et al [13] BOULAAJAJ et al [12], ZAHEDI et al [18] noted zero prevalence. In India, MITTAL et al [19] reported a low frequency of 1.7% but HALLE et al [14] found a rate of 9.1% in Cameroon. These low prevalences could be explained by the implementation in these low-endemic countries of effective prevention strategies for the control of viral infections transmitted by blood transfusion.…”

Section: Discussionmentioning

confidence: 98%

“…In Africa, from Morocco, BOULAAJAJ et al [12] found a seroprevalence of 2% upon 199 hemodialysis patients while EL YOUBI et al [13] in 2008, reported 12.2% from 90 patients. From sub-Saharan countries, HALLE et al [14] reported 6% in Cameroon in 2016 based on 86 chronic hemodialysis patients. In Ivory Coast, area closed to Togo, KOUASSI-M'BENGUE et al [5] reported a rate of 17.6% in 2010.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence and Factors Associated with Hepatitis B Virus Surface Antigen and Human Immunodeficiency Virus Antibodies in Chronic Hemodialysis Patients Followed-Up in Lomé, Togo

Salou¹,

Sabi²,

Tevi³

et al. 2019

OJMM

View full text Add to dashboard Cite

Introduction: In haemodialysis patients, the risk of acquiring blood-borne viral infections is an important cause of the dialysis's process. Indeed, viral infections are quite common in chronic haemodialysis patients including those due to viral hepatitis B and HIV. Objective: Determine the prevalence of HIV infection and hepatitis B infection among chronic hemodialysis patients of Togo. Methods: A cross-sectional study was conducted in chronic hemodialysis patients of Togo from January 1 st to December 31 st , 2016. Sociodemographic and clinical data were collected. Antigen HBs was screened by a rapid immunochromatographic test (SD BIOLINE  HBsAg), and HIV antibodies were detected using a combination of 2 rapid diagnostic test, SD BIOLINE  HIV-1/2 (first step) and TRIDOT test (second step). Results: During the study period, 95 subjects were included. Patient's age was ranking from 13 to 80 years with a mean of 46.6 years. The sex-ratio (M/F) was 1.8 and a duration average of dialysis was 51.7 months. The aetiologies of the chronic endstage kidney failure were related respectively to a vascular renal disease for 42.1% of the patients, glomerular nephropaty for 34.74%, interstitial nephropaty for 9.47% and hereditary for 3.16%. For 10.53% of the patients, the initial renal disease remained indefinite. Prevalence of antigen HBs and HIV antibodies were respectively 10.

show abstract

Section: Discussionmentioning

confidence: 98%

Section: Discussionmentioning

confidence: 99%

Prevalence and Factors Associated with Hepatitis B Virus Surface Antigen and Human Immunodeficiency Virus Antibodies in Chronic Hemodialysis Patients Followed-Up in Lomé, Togo

Salou¹,

Sabi²,

Tevi³

et al. 2019

OJMM

View full text Add to dashboard Cite

show abstract

Incidence de la séroconversion de l’hépatite virale B et du VIH chez les hémodialysés chroniques à Douala, Cameroun

Cited by 1 publication

References 0 publications

Prevalence and Factors Associated with Hepatitis B Virus Surface Antigen and Human Immunodeficiency Virus Antibodies in Chronic Hemodialysis Patients Followed-Up in Lomé, Togo

Prevalence and Factors Associated with Hepatitis B Virus Surface Antigen and Human Immunodeficiency Virus Antibodies in Chronic Hemodialysis Patients Followed-Up in Lomé, Togo

Contact Info

Product

Resources

About

Incidence de la séroconversion de l’hépatite virale B et du VIH chez les hémodialysés chroniques à Douala, Cameroun

Cited by 1 publication

References 0 publications

Prevalence and Factors Associated with Hepatitis B Virus Surface Antigen and Human Immunodeficiency Virus Antibodies in Chronic Hemodialysis Patients Followed-Up in Lom&#233;, Togo

Prevalence and Factors Associated with Hepatitis B Virus Surface Antigen and Human Immunodeficiency Virus Antibodies in Chronic Hemodialysis Patients Followed-Up in Lom&#233;, Togo

Contact Info

Product

Resources

About

Prevalence and Factors Associated with Hepatitis B Virus Surface Antigen and Human Immunodeficiency Virus Antibodies in Chronic Hemodialysis Patients Followed-Up in Lomé, Togo

Prevalence and Factors Associated with Hepatitis B Virus Surface Antigen and Human Immunodeficiency Virus Antibodies in Chronic Hemodialysis Patients Followed-Up in Lomé, Togo